GL1X · GenesisL1 explorer

MolNFT v1 · #186001 · protein

X-ray structure of the adduct obtained upon reaction of [cis- RH2(OCOCH3)2(OCOCF3)2] with RNase a (4)

7QPZ · Ribonuclease pancreatic: “X-ray structure of the adduct obtained upon reaction of [cis- RH2(OCOCH3)2(OCOCF3)2] with RNase a (4)”. X-ray diffraction, 2 ligands (F5I, F5T), 1 pocket (best druggability 0.27). MolNFT v1 #186001 on…

PDB
7QPZ
Type
protein
Length
244 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribonuclease pancreatic
EC
4.6.1.18
UniProt
P61823
Ligands
F5I, F5T
Pockets
1 · best druggability 0.27

Structure

x-ray diffraction · 2 distinct chains · 21% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARibonuclease pancreatic (EC 4.6.1.18)protein12421% helix, 35% strandP61823
BRibonuclease pancreatic (EC 4.6.1.18)protein12022% helix, 37% strandP61823

Ligands and binding sites

  • F5I · cis-bis(mi2-acetato-O, O')-tetraaquo-dirhodium(II) · ligand · 2 copies · chains A, B
  • F5T · cis-bis(mi2-acetato-O, O')-(mi2-trifluoroacetato-O, O')-diaquo-dirhodium (II) · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1510.270.7415empty

Interfaces

1 interface between chains.

  • A–B · 330 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 7QPZ · X-ray structure of the adduct obtained upon reaction of [cis-Rh2(OCOCH3)2(OCOCF3)2] with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.